InsiderTrades

Form 4 for SLSN SOLESENCE, INC.

Accepted 2022-11-14 00:00:00 ET · period of report 2022-11-10 · accession 0001209191-22-056830 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-11-14 2012-11-11+ SLSN JANKOWSKI JESS Pres, CEO, Dir M - OptEx $0.42 +13.3K 59.2K +29% +$5,580
DM 2022-11-14 2022-11-10+ SLSN JANKOWSKI JESS Pres, CEO, Dir S - Sale+OE $1.93 -13.3K 59.0K -18% -$25.6K
DM 2022-11-14 2022-11-10+ SLSN JANKOWSKI JESS Pres, CEO, Dir M - OptEx $0.42 -13.3K 55.9K -19% -$5,580

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-11-14 M A 6,500 $0.42 65,500 D — — (F1) These stock options are set to expire on 02/14/2023. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors.
2 Common Common Stock 2022-11-14 S D 6,500 $1.90 59,000 D — —
3 Common Common Stock 2022-11-11 S D 4,986 $1.95 59,000 D — —
4 Common Common Stock 2012-11-11 M A 4,986 $0.42 63,986 D — — (F1) These stock options are set to expire on 02/14/2023. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors.
5 Common Common Stock 2022-11-11 S D 1,400 $1.96 59,000 D — —
6 Common Common Stock 2022-11-11 M A 1,400 $0.42 60,400 D — — (F1) These stock options are set to expire on 02/14/2023. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors.
7 Common Common Stock 2022-11-11 S D 200 $1.97 59,000 D — —
8 Common Common Stock 2022-11-10 S D 200 $2.10 59,000 D — —
9 Common Common Stock 2022-11-10 M A 200 $0.42 59,200 D — — (F1) These stock options are set to expire on 02/14/2023. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors.
10 Common Common Stock 2022-11-11 M A 200 $0.42 59,200 D — — (F1) These stock options are set to expire on 02/14/2023. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors.
11 Derivative Common Stock (right to purchase) 2022-11-11 M D 6,586 $0.42 62,431 D $0.42 · 2014-02-14 to 2023-02-14 69,017 Common Stock (F2) These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker. His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors.
12 Derivative Common Stock (right to purchase) 2022-11-10 M D 200 $0.42 69,017 D $0.42 · 2014-02-14 to 2023-02-14 69,217 Common Stock (F2) These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker. His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors.
13 Derivative Common Stock (right to purchase) 2022-11-14 M D 6,500 $0.42 55,931 D $0.42 · 2014-02-14 to 2023-02-14 62,431 Common Stock (F2) These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker. His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors.